ACTSI Investigator Dr. David Weiss in the News

David Weiss, PhD, ACTSI investigator, assistant professor, Division of Infectious Diseases, School of Medicine, and director, Emory Antibiotic Resistance Center, Emory University

The Australian | CIDRAP | Superbugs pretend to be vulnerable to medication  
May 10, 2016

Emory News Center | Fooling the test: Antibiotic resistant bacteria look susceptible
May 9, 2016

The Scientist | Serious putty
May 1, 2016

Emory Woodruff Health Sciences Center Update | Center brings "all hands on deck" to address antibiotic resistance
September 24, 2015

Weiss received the Levy Award for junior faculty for examining ways in which bacterial pathogens resist antibiotics and evade the host immune system, so as to combat drug-resistant bacteria.

Weiss received VA Merit Award funding for his project entitled, “Molecular Mechanisms of Antibiotic Resistance in Acinetobacter baumannii.”

Weiss is an awardee of the Burroughs Wellcome “Investigators in the Pathogenesis of Infectious Disease” program. This program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. The award provides $500,000 over a period of five years.

Weiss was honored as a MilliPub Club member which honors faculty who have published papers garnering 1,000 or more citations. Read More

“A PmrB-regulated deacetylase required for Lipid A modification and polymyxin resistance in Acinetobacter baumannii.” Antimicrob Agents Chemother. 2015 Dec;59(12):7911-4. Read more… 

“Disseminated emm type 12 Group A Streptococcus and review of invasive disease.“ Am J Med Sci. 2015 Nov;350(5):429-31. Read more… 

“Cas9-mediated targeting of viral RNA in eukaryotic cells.” Proc Natl Acad Sci U S A. 2015 May 12;112(19):6164-9. Read more…

“Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme.” Antimicrob Agents Chemother. 2014 Sep;58(9):5594-7. Read more…

“A Francisella virulence factor catalyses an essential reaction of biotin synthesis.” Mol Microbiol 2014 Jan;91(2):300-14. Read more…

“Exploiting CRISPR/Cas systems for biotechnology.” Bioessays 2014 Jan;36(1):34-8. Read more…

“Cas9-dependent endogenous gene regulation is required for bacterial virulence.” Biochem Soc Trans 2013 Dec;41(6):1407-11. Read more…

PET Imaging of Bacterial Infections with Fluorine-18-labeled Maltohexaose

Arteriosclerosis, Thrombosis, and Vascular Biology
Polymerase δ-Interacting Protein 2 Promotes Postischemic Neovascularization of the Mouse Hindlimb

Semi-degradable Poly(β-amino ester) Networks with Temporally Controlled Enhancement of Mechanical Properties

Upcoming Events

    View All Events

    Latest News


    ACTSI-supported OculoStaple Wins Again

    Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...


    Infographic: What are the Phases of Clinical Trials?